Drug Profile
Research programme: vaccines - Parabon NanoLabs
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Parabon NanoLabs
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ricin poisoning
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Ricin poisoning in USA
- 07 Dec 2012 Preclinical trials in Ricin poisoning in USA (unspecified route)